Elevated cerebrospinal fluid levels of substance P in patients with the fibromyalgia syndrome.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Elevated cerebrospinal fluid levels of substance P in patients with the fibromyalgia syndrome.
- Published In:
- Arthritis and rheumatism, 37(11), 1593-601 (1994)
- Authors:
- Russell, I J, Orr, M D, Littman, B, Vipraio, G A, Alboukrek, D, Michalek, J E, Lopez, Y, MacKillip, F
- Database ID:
- RPEP-00306
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-00306APA
Russell, I J; Orr, M D; Littman, B; Vipraio, G A; Alboukrek, D; Michalek, J E; Lopez, Y; MacKillip, F. (1994). Elevated cerebrospinal fluid levels of substance P in patients with the fibromyalgia syndrome.. Arthritis and rheumatism, 37(11), 1593-601.
MLA
Russell, I J, et al. "Elevated cerebrospinal fluid levels of substance P in patients with the fibromyalgia syndrome.." Arthritis and rheumatism, 1994.
RethinkPeptides
RethinkPeptides Research Database. "Elevated cerebrospinal fluid levels of substance P in patien..." RPEP-00306. Retrieved from https://rethinkpeptides.com/research/russell-1994-elevated-cerebrospinal-fluid-levels
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.